IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C.
- Bochud, Pierre-Yves
- Bibert, Stéphanie
- Negro, Francesco
- Haagmans, B
- Soulier, Anthony André
- Ferrari, C
- Missale, G
- Zeuzem, S
- Pawlotsky, J-M
- Schalm, S
- Hellstrand, K
- Neumann, A U
- Lagging, M
DOIAbstract
Single nucleotide polymorphisms (SNPs) associated with IL28B influence the outcome of peginterferon-α/ribavirin therapy of chronic hepatitis C virus (HCV) infection. We analyzed the kinetics of HCV RNA during therapy as a function of IL28B SNPs
Add to ORKG